Author:
Shapiro Bruce S.,Daneshmand Said T.,Garner Forest C.,Aguirre Martha,Thomas Shyni
Subject
Obstetrics and Gynecology,Reproductive Medicine
Reference7 articles.
1. Ovarian hyperstimulation syndrome;Practice Committee of the American Society for Reproductive Medicine;Fertil Steril,2003
2. Effects of the ovulatory serum concentration of human chorionic gonadotropin on the incidence of ovarian hyperstimulation syndrome and success rates for in vitro fertilization;Shapiro;Fertil Steril,2005
3. Serum inhibin A, VEGF and TNF alpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial;Babayof;Hum Reprod,2006
4. Engmann L, DiLuigi A, Schmidt D, Nulsen J, Maier D, Benadiva C. The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study. Fertil Steril. In press.
5. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study;Humaidan;Hum Reprod,2005
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献